Activation of CD8 T cells by mycobacterial vaccination protects against pulmonary tuberculosis in the absence of CD4 T cells

Journal of Immunology

Volumn 173, Issue 7, 2004, Pages 4590-4597

  Wang, Jun ^a   Santosuosso, Michael ^a   Ngai, Patricia ^a   Zganiacz, Anna ^a   Xing, Zhou ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; MYCOBACTERIUM VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; EFFECTOR CELL; LUNG; LUNG TUBERCULOSIS; LYMPH NODE; LYMPHOCYTE FUNCTION; MEMORY CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION;

EID: 4644309271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.7.4590     Document Type: Article

References (41)

1. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. JAMA 282:677.
2. Raviglione, M. C. 2003. The TB epidemic from 1992 to 2002. Tuberculosis 83:4.
3. Corbett, E. L., C. Watt, N. Walker, D. Maher, E.G. Williams, M.C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009.
4. Kaufmann, S. H. E. 2001. How can immunology contribute to the control of tuberculosis. Nat. Rev. Immunol. 1:20.
5. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
6. Xing, Z. 2001. The hunt for new tuberculosis vaccines: anti-TB immunity and rational design of vaccines. Curr. Pharm. Des. 7:1015.
7. Ottenhoff, T. H., T. De Boer, J. T. van Dissel, and F. A. Verreck. 2003. Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Adv. Exp. Med. Biol. 531:279.
8. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:2243.
9. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
10. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
11. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
12. + T-helper and a T-killer cell. Nature 393:474.
13. + T cells during Mycobacterium tuberculosis infection. J. Immunol. 167:6991.
14. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
15. Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111:927.
16. + T lymphocytes. Nature 421:852.
17. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337.
18. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 300:339.
19. + T cells. Infect. Immun. 55:2037.
20. + cells in the immunologic control of infection with Mycobacterium bovis strain bacillus Calmette-Guérin in mice: assessment by elimination of T cell subsets in vivo. J. Immunol. 139:2032.
21. Leveton, C., S. Barnass, B. Champion, S. Lucas, B. De Souza, M. Nicol, D. Banerjee, and G. Rook. 1989. T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis. Infect. Immun. 57:390.
22. Flory, C. M., R. D. Hubbard, and F. M. Collins. 1992. Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. J. Leukocyte Biol. 51:225.
23. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013.
24. Xing, Z., J. Wang, K. Croitoru, and J. Wakeham. 1998. Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Infect. Immun. 66:5537.
25. Behar, S. M., C. C. Dascher, M. J. Grusby, C. R. Wang, and M. B. Brenner. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973.
26. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271.
27. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis. J. Immunol. 162:5407.
28. Silva, C. L., V. L., Bonato, V. M. Lima, L. H. Faccioli, and S. C. Leao. 1999. Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination. Immunology 97:573.
29. Orme, I. M., and F. M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis-infected lung: dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell. Immunol. 84:113.
30. + T cells requires the production of γ interferon. Infect. Immun. 66:830.
31. Wang, J., A. Zganiacz, and Z. Xing. 2002. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 20:2887.
32. Chen, L., J. Wang, A. Zganiacz, and Z. Xing. 2004. Single intranasal mucosal BCG vaccination confers improved immune protection over subcutaneous vaccination against pulmonary tuberculosis. Infect. Immun. 72:238.
33. Wakeham, J., J. Wang, J. Magram, K. Croitoru, R. Harkness, P. Dunn, A. Zganiacz, and Z. Xing. 1998. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice. J. Immunol. 160:6101.
34. Zganiacz, A., M. Santosuosso, J. Wang, T. Yang, L. Chen, M. Anzulovic, S. Alexander, B. Gicquel, Y. H Wan, J. Bramson, M. Inman, and Z. Xing. 2004. TNFα is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113:401.
35. + T cells in the priming and effector/memory phases of adoptive immunotherapy. J. Immunol. 165:4246.
36. Shedlock, D. J., J. K. Whitmire, J. Tan, A. S. MacDonald, R. Ahmed, and H. Shen. 2003. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J. Immunol. 170:2053.
37. + T-cell responses against malaria liver stages. Nat. Med. 8:166.
38. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12:336.
39. + T cells. Immunol. Rev. 186:221.
40. Muller, G., and M. Lipp. 2003. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 10:325.
41. Tyznik, A. J., J. C. Sun, and M. J. Bevan. 2004. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J. Exp. Med. 199:559.